Latest News

 Filter by Provider

Since becoming CEO, Ryan Cohen has redefined GameStop's business and invested company funds outside of retailing.

Prediction markets offer a unique way to make money, even if top cryptocurrencies are in the red.

Achieving a perfect 850 credit score takes decades. But you can copy the same habits and still get top loan rates and credit cards.

Pfizer has fallen behind the pack when it comes to GLP-1 drugs, but the company is still fighting.

They are great long-term options.

You may not be able to predict exactly how long you'll live, but it's a good idea to plan for a longer-than-expected life.

The conglomerate is still the ultimate sleep-well-at-night stock.

There are still trends playing in its favor in 2026.

A 10% owner of Under Armour purchased multiple shares of the company towards the end of January 2026. Is this a signal to purchas UA stock?

The Vanguard Information Technology ETF gives investors positions in leading tech companies, but it comes with risk.

Consumer staples stocks being out of favor is an impeccable buying opportunity for value investors.

The market keeps rewarding this business, as shares benefit from positive momentum.

Don't invest in the SpaceX IPO until you understand the Starlink business.

XRP was above $3 in 2025, and it might soon be once again.

All three of these AI stocks should have tremendous momentum this year.

These AI stocks are inexpensive for a simple reason: They should grow by leaps and bounds.

This week, key stories include Trump briefed on Iran's weakening regime, Newsom urging Californians to report federal misconduct.

Can Peloton be the year's biggest turnaround story?

YouTube aggressively removes AI-generated spam content to maintain its status as a top advertising and streaming destination.

There's a reason many retirees may be disappointed in their benefits this year.

Maze Therapeutics' Senior Vice President of Finance sold shares towards the end of January 2026, all while the company's stock had one of the best first-year performances of a biopharmaceutical company.

Workers with median earnings can build sizable portfolios that pay a substantial amount of passive income.

Costco and Walmart are two of the world's largest retailers.

Wall Street's foundational financial institution is rife with red flags, and the stock market could pay the price.

Beam Therapeutics specializes in gene-editing medicines, and recently, the company's Senior Vice President edited out thousands of shares from her portfolio.

These Vanguard funds won't necessarily keep you from losing money if the market crashes. But they can help cushion the blow.

Retirees' 2026 Social Security COLA might taste a little better after a recent government report.

A Detroit judge and three others were indicted for allegedly embezzling funds from incapacitated individuals, including misusing estates.

Eric Schmidt says AI is underestimated but will revolutionize finance, healthcare. AI is automating boring business tasks.

In all three cases it started with a must-have product or service that's easy and affordable enough to buy over and over again.

AMD has a foot in the door of the booming space economy.

Sandisk stock increased 16x in the past year as demand for artificial intelligence infrastructure led to a severe supply shortage in memory chips and storage devices.

Billionaires are buying this maker of critical mapping and positioning software at a discount.

The CEO of this leading medical diagnostic company sold shares throughout multiple days in January. But the manner in which the shares were sold shouldn't concern investors.

The Delaware Supreme Court cut Tesla's shareholder lawsuit legal fees to $70.9M while upholding a $919M director compensation settlement.

Leisure stocks can provide good returns, if you can ride out the waves during economic downturns.

This top executive at Harmony Biosciences previous sold all of his direct shares in the company in early January 2026. But towards the end of the month, some options and restricted stock units vested, and everything changed.

President Donald Trump expressed confidence that his Fed nominee, Kevin Warsh, could win bipartisan Senate support.

These two stock-split stocks still have a long runway ahead.

Investor and TV personality Kevin O'Leary endorses a nationwide child investment policy, emphasizing its bipartisan appeal.

The Chief Scientific Officer of Scholar Rock Holding Corp has made multiple filings regarding disposals in January 2026, but this should not alarm investors.

Ford reportedly had preliminary discussions with Xiaomi about a joint venture, aiming to facilitate Chinese carmakers' entry into the U.S. market.

Beyond Meat was a market darling when it first went public, but you'll want to tread cautiously if you are looking to buy it today.

Trump announced Homeland Security will only intervene in Dem cities' protests if asked, while Fed buildings will be protected as backup.

Despite recent safety concerns, Waymo continues to expand operations and faces potential impact on industry.

A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual performance ever in 2025.

Nio is an innovative auto company operating in the world's largest auto market, but I'm still bearish on it.

Transportation Secretary Pete Buttigieg criticized Trump administration and Republicans for rising costs, stalled healthcare relief.

Brookfield Renewable has high-powered total return potential.

The Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.